Reuters logo
BRIEF-Merck to present new data from clinical trials at IAS 2017
2017年7月6日 / 上午11点08分 / 4 个月前

BRIEF-Merck to present new data from clinical trials at IAS 2017

July 6 (Reuters) - Merck & Co Inc

* Merck to present new data from clinical trials evaluating Isentress HD (raltegravir) and investigational HIV therapies Doravirine and MK-8591 at IAS 2017

* Merck says late-breaker abstract will be presented of a phase 1 study of MK-8591, Merck’s investigational NRTTI in adult patients with HIV-1 infection​

* Merck - ‍recommendation is under review by European commission for marketing authorization in EU with decision on approval expected in H2 of 2017​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below